Close Menu

This article has been updated from a previous version to include additional information about the saliva collection device specified in the EUA summary.

NEW YORK – The US Food and Drug Administration on Friday granted Emergency Use Authorization to the Rutgers Clinical Genomics Laboratory for a SARS-CoV-2 test originally developed by Thermo Fisher Scientific that is modified for use on additional specimen types, including saliva, as well as with alternative nucleic acid extraction and amplification systems.

To read the full story....

...and receive Daily News bulletins.

Already have a 360Dx or GenomeWeb account?
Login Now.

Don't have a 360Dx or GenomeWeb account?
Register for Free.